Top Injectable Manufacturer in Thailand – Reliable Pharmaceutical Solutions
- Maulik Sudani
- 8 hours ago
- 8 min read
Last Updated: July 12, 2026
TL;DR: Thailand — a nation of more than 72 million people with one of Southeast Asia's most developed health systems and universal health coverage delivered through three schemes — depends on a reliable, compliant supply of sterile injectables for its hospitals, its social-insurance programmes and its public procurement, and it imports a large share of its finished injectables and the overwhelming majority of its active pharmaceutical ingredients. Every imported sterile injectable must hold a marketing authorisation (product registration) issued by the Thai Food and Drug Administration (Thai FDA) under the Ministry of Public Health, be registered and imported by a Thai-incorporated licence holder that holds an import licence, be filed in ASEAN Common Technical Dossier (ACTD) format (ICH-CTD is also accepted), be supported by a Certificate of Pharmaceutical Product and a foreign GMP certificate recognised under PIC/S, and be manufactured to WHO-GMP standards with Thai-language labelling. Farbe Firma Pvt Ltd is a WHO-GMP certified injectable manufacturer in Thailand's supply chain and a CDMO in Gujarat, India, producing more than 100 sterile injectables under ISO Class 5 aseptic conditions and exporting to 30+ countries, with complete CTD/ACTD dossiers, drug master files and ICH stability data ready to support Thai FDA registration and hospital, NHSO and GPO-linked procurement tenders for Thai partners.
Key Takeaways
Market and regulatory pathway: every sterile injectable entering Thailand must hold a marketing authorisation (product registration) from the Thai Food and Drug Administration (Thai FDA), be registered and imported by a Thai-incorporated licence holder holding an import licence, be filed in ACTD format (ICH-CTD accepted) and be backed by a Certificate of Pharmaceutical Product and a foreign GMP certificate recognised under PIC/S; Farbe Firma builds every dossier and supply arrangement around Thai FDA requirements and the public procurement system (Universal Coverage/NHSO, CSMBS, the Social Security Scheme, the NLEM and the GPO).
Certified manufacturing: WHO-GMP certified plant with an ISO Class 5 aseptic core, validated water-for-injection loops, terminal moist-heat sterilisation where the formulation qualifies and full aseptic processing where it does not, HPLC and LAL testing and 100% visual inspection on every batch.
CTD/ACTD dossier support: full ACTD and CTD/eCTD modules, ICH Q1A long-term and accelerated stability and ICH Q1B photostability data generated for Climatic Zone IVb, sterilisation and container-closure packages, drug master files and Certificate-of-Pharmaceutical-Product documentation for Thai FDA registration, National List of Essential Medicines (NLEM) listing and public hospital, NHSO and GPO-linked tenders.
End-to-end CDMO services: contract and third-party manufacturing across 100+ sterile injectables — ampoules, vials, lyophilised products and pre-filled presentations — with Thai-language artwork and leaflets, tamper-evident tender-ready packaging and import/export coordination to Laem Chabang, Bangkok and beyond.
Introduction: Why an Injectable Manufacturer in Thailand Must Meet Global Standards
Thailand is one of the most developed pharmaceutical markets in Southeast Asia, serving more than 72 million people through a health system with genuine universal coverage delivered by three schemes — the Universal Coverage Scheme administered by the National Health Security Office (NHSO), the Civil Servant Medical Benefit Scheme (CSMBS) for public employees, and the Social Security Scheme (SSS) for private-sector workers — alongside a large public hospital network and a fast-growing private and medical-tourism sector. Across all of them the demand for sterile injectables is immense — antibiotics, anaesthetics, emergency and critical-care drugs, oncology therapies, analgesics, anti-emetics and maternal-health products. Every one of them has to reach hospitals and clinics sterile, correctly labelled and exactly to specification, batch after batch, whether it is destined for a university hospital in Bangkok or Chiang Mai or a district hospital in the north-eastern Isan region or the southern provinces.
Although Thailand has a domestic pharmaceutical industry — led by the state-owned Government Pharmaceutical Organization (GPO) — it still imports a large share of its finished sterile injectables and the overwhelming majority of its active pharmaceutical ingredients, which makes a reliable overseas manufacturing partner strategically important. That partner must clear a demanding regulatory pathway: every product must hold a marketing authorisation (product registration) issued by the Thai Food and Drug Administration (Thai FDA) under the Ministry of Public Health; a Thai-incorporated company holding a manufacturing or import licence must hold the registration, because a foreign company cannot hold a Thai FDA licence directly; the dossier must be prepared in the ASEAN Common Technical Dossier (ACTD) format, with the ICH-CTD also accepted, and submitted through the Thai FDA electronic system; the manufacturing site must be covered by a valid GMP certificate recognised under PIC/S, of which Thailand is a member, together with a Certificate of Pharmaceutical Product; and labelling must suit the market in Thai. An injectable manufacturer that wants to serve Thailand well has to treat these requirements not as afterthoughts but as core design inputs — which is exactly how Farbe Firma approaches the market.
What Sets a World-Class Injectable Manufacturer in Thailand Apart
The first differentiator is genuine sterile-manufacturing capability. A world-class injectable manufacturer serving Thailand runs a WHO-GMP certified plant with an ISO Class 5 (Grade A) aseptic core, validated water-for-injection generation and looped distribution, qualified HVAC with continuous environmental monitoring, and both terminal moist-heat sterilisation and full aseptic processing so that each product is made by the route its formulation and container actually justify. It backs that with a proper analytical laboratory — stability-indicating HPLC assay and related-substance control, bacterial endotoxin testing by LAL, sterility testing, and particulate and container-closure-integrity checks — and a broad portfolio of more than 100 injectables in ampoule, vial, lyophilised and pre-filled formats, so a Thai importer, hospital group or distributor can consolidate many product needs with a single qualified source. Because the Thai FDA is a PIC/S member, a manufacturer that already runs to a PIC/S-grade GMP standard is directly recognisable to Thai reviewers.
The second differentiator is registration and market-access support built specifically around Thailand. Because the Thai FDA reviews dossiers in ACTD format, a strong partner prepares complete, review-ready ACTD and CTD/eCTD modules with ICH Q1A stability and ICH Q1B photostability data, drug master files, sterilisation and container-closure reports, method-validation packages, a Certificate of Pharmaceutical Product and a PIC/S-recognised GMP certificate — the documentation a Thai licence holder's regulatory team needs to register a product and keep it current through the renewal cycle. It supplies Thai artwork and package inserts and packages products to compete in public procurement, where the Universal Coverage Scheme (NHSO), the CSMBS and the Social Security Scheme shape demand, the National List of Essential Medicines (NLEM) defines what public hospitals buy, and the GPO and public hospitals run the tenders. This combination of manufacturing depth and Thailand-specific dossier and labelling support is what separates a true injectable manufacturer in Thailand's supply chain from a mere exporter.
Quality Systems Behind Every Batch We Ship to Thailand
Every Farbe Firma injectable batch destined for Thailand is released only after a full stack of quality checks: stability-indicating HPLC assay against pharmacopoeial reference standards, control of related substances and degradation products, solution pH and clarity, deliverable volume, visible and sub-visible particulate matter, bacterial endotoxin by LAL, sterility by membrane filtration, and container-closure integrity for the ampoule, vial or pre-filled format. Certificates of analysis are issued with full traceability back to each API lot, the primary-packaging lot and the qualified person responsible for release, so a Thai licence holder's regulatory-affairs team and Thai FDA reviewers can see a complete, auditable chain from raw material to finished unit.
Around those release tests sits a deeper quality architecture: validated water-for-injection systems, qualified and monitored cleanrooms, validated sterilisation and depyrogenation equipment, validated filling lines with 100% inspection, and an electronic batch-record system tied into formal deviation, change-control and CAPA workflows. Stability is tracked under both long-term (30 °C / 75 % RH, the ICH Climatic Zone IVb condition appropriate to Thailand's hot-and-humid tropical monsoon climate) and accelerated (40 °C / 75 % RH) conditions, with a photostability challenge where relevant, so registered shelf lives are supported by data generated under conditions that reflect how the product will actually be stored and transported — from the ports of Laem Chabang and Bangkok to hospitals across the central plains, the north and the south.
Looking for a sterile injectable manufacturing partner? Submit a Quick Inquiry
Why Farbe Firma is the Trusted Injectable Manufacturer in Thailand for Global Buyers
Farbe Firma Pvt Ltd manufactures more than 100 sterile injectables at its WHO-GMP certified facility in Gujarat, India, spanning antibiotic, anaesthesia, emergency and critical-care, gastrointestinal, anti-emetic, analgesic, vitamin and specialty ranges — the categories Thai hospitals, distributors and public institutions buy in the largest volumes. For Thai partners we supply finished sterile injectables ready for Thai FDA registration, with market-specific strengths, fill volumes, Thai artwork and tamper-evident tender packs available under contract-manufacturing agreements, and every batch released to WHO-GMP standards with its ACTD data package and Certificate of Pharmaceutical Product ready for the licence holder's product-registration filing.
Our CDMO services scale cleanly from a single distributor's launch portfolio to full hospital, NHSO and GPO-linked tender supply under the universal-coverage system. We prepare complete ACTD and CTD/eCTD modules, drug master files, ICH Q1A stability and ICH Q1B photostability packages, assay and related-substance method-validation data, sterilisation and container-closure reports, a Certificate of Pharmaceutical Product, a PIC/S-recognised GMP certificate, and Thai inserts and artwork. Our regulatory, manufacturing and logistics teams coordinate registration timelines, line slots and shipping to Laem Chabang, Bangkok and other ports of entry as a single, managed programme rather than a series of disconnected transactions.
Buyers stay with Farbe Firma because of audit-readiness and communication. Thai importers, distributors and their auditors are welcomed onto the plant floor and into the compounding and filling suites; our quality unit answers technical and regulatory queries with primary data rather than slogans; and our reviewer team — practising pharmacists and R&D scientists — can talk through API sourcing, sterile-process design, stability strategy for a Zone IVb climate, ACTD dossier structure, Thai FDA registration steps, PIC/S GMP expectations and tender documentation in real detail. For an importer or hospital group that has to answer to the Thai FDA, to the NHSO and to its own patients, that transparency is exactly what makes a distant manufacturer feel like a dependable local partner.
Explore Farbe Firma: Products | Global Reach | About Us
Frequently Asked Questions (FAQ)
Is Farbe Firma a WHO-GMP certified injectable manufacturer that can supply Thailand?
Yes. Farbe Firma Pvt Ltd holds WHO-GMP certification and manufactures more than 100 sterile injectables at its Gujarat, India facility with ISO Class 5 aseptic processing, validated water-for-injection systems, terminal and aseptic sterilisation routes, HPLC and LAL testing, 100% inspection and continuous environmental monitoring. We already export to 30+ countries and prepare every batch and dossier to support import and Thai FDA registration in Thailand through a Thai-incorporated licence holder, with GMP maintained to a PIC/S-recognised standard.
How does Farbe Firma support Thai FDA drug registration in Thailand?
We provide complete ACTD and CTD/eCTD modules, drug master files, ICH Q1A stability (for Climatic Zone IVb) and ICH Q1B photostability data, sterilisation and container-closure reports, method-validation packages, a Certificate of Pharmaceutical Product and a foreign PIC/S-recognised GMP certificate — the technical documentation a Thai licence holder's regulatory team needs to obtain a product registration from the Thai Food and Drug Administration (Thai FDA). We also supply Thai artwork and package inserts.
Can Farbe Firma supply injectables for Thai public hospital, NHSO and GPO tenders?
Yes. Much of Thailand's public-sector demand is met through procurement financed by the Universal Coverage Scheme (NHSO), the Civil Servant Medical Benefit Scheme and the Social Security Scheme, shaped by the National List of Essential Medicines (NLEM), with the GPO and public hospitals running the tenders. We package products to be tender-ready — with the right strengths, fill volumes, Thai artwork and tamper-evident presentations — and provide the registration dossier, PIC/S-recognised GMP evidence and Certificate of Pharmaceutical Product that a licence holder or distributor needs to compete.
Which injectables can Farbe Firma supply to Thai hospitals and tenders?
Our portfolio of 100+ sterile injectables covers antibiotics, anaesthetics, emergency and critical-care drugs, analgesics, anti-emetics, gastrointestinal agents, vitamins and specialty products in ampoule, vial, lyophilised and pre-filled formats. We package products to be tender-ready for public hospital, NHSO and GPO-linked procurement and private hospital groups, with market-specific strengths and pack sizes available under contract.
What is the minimum order quantity for injectable contract manufacturing for Thailand?
MOQs vary by product, format, sterilisation route, label complexity and dossier requirements. We accommodate single-distributor launch quantities as well as full hospital- and public-tender-scale supply for the Thai market. Contact director@farbefirma.org for a specific quotation and a registration and supply plan for your product list.
Technically Reviewed By: Maulik Sudani | Jignasu Sudani (Technical Expert)
Website: www.farbefirma.org | Email: director@farbefirma.org | Address: Gujarat, INDIA
Request a Quote | View Products | FAQ | Blog